Arthrosi Therapeutics
$950.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Arthrosi Therapeutics is currently valued at $950.0M as of December 13, 2025. The company has raised a total of $298.8M in funding.
Capital Efficiency
With a capital efficiency ratio of 3.18x, Arthrosi Therapeutics has achieved a valuation that is 3.18 times the total capital raised. This metric indicates strong capital efficiency and effective deployment of investor funds.
Investment Perspective
Arthrosi Therapeutics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Arthrosi Therapeutics Worth in 2025?
As of 2025, Arthrosi Therapeutics is valued at $950.0M, based on the company's Merger/Acquisition funding round in December 13, 2025. This valuation positions Arthrosi Therapeutics as one of the leading private companies in the sector.
Arthrosi Therapeutics Valuation History
Arthrosi Therapeutics's funding history demonstrates steady growth and investor confidence.
How Arthrosi Therapeutics Valuation is Determined
Private company valuations like Arthrosi Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Arthrosi Therapeutics Valuation FAQs
Is Arthrosi Therapeutics profitable?
Arthrosi Therapeutics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Arthrosi Therapeutics's valuation compare to competitors?
Arthrosi Therapeutics is valued at $950.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Arthrosi Therapeutics IPO?
Arthrosi Therapeutics has not announced plans for an initial public offering. Until an IPO, investors can access Arthrosi Therapeutics shares through secondary market platforms.